Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

Historical Holders from Q1 2019 to Q1 2025

Symbol
ARMP on NYSE
CUSIP
04216R102
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
75.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.39M
Holdings value
$2.57M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
22
Number of buys
5
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Innoviva, Inc. 85.2% $126M 64.2M Innoviva, Inc. Mar 12, 2025

Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 35.1K $51.2K $1.46 2
2024 Q4 1.39M $2.57M +$5.74K $1.85 22
2024 Q3 1.38M $3.28M -$52.1K $2.37 21
2024 Q2 1.4M $3.86M -$42.3K $2.75 21
2024 Q1 1.42M $5.93M +$547K $4.18 22
2023 Q4 1.29M $4.17M +$25.7K $3.24 23
2023 Q3 1.28M $3.84M +$327K $3.00 21
2023 Q2 1.19M $1.35M -$74.3K $1.14 20
2023 Q1 1.23M $2.06M -$89.1K $1.67 21
2022 Q4 1.3M $1.61M -$228K $1.24 25
2022 Q3 1.36M $5.73M +$37K $4.22 15
2022 Q2 1.35M $5.25M -$7.46K $3.88 15
2022 Q1 1.35M $6.61M +$139K $4.89 15
2021 Q4 1.32M $7.25M +$738K $5.48 15
2021 Q3 1.19M $4.32M +$125K $3.62 16
2021 Q2 523K $2.07M -$184K $3.97 15
2021 Q1 1.18M $5.62M +$1.49M $4.79 18
2020 Q4 868K $2.59M -$12.9K $2.99 12
2020 Q3 875K $2.79M +$51.4K $3.19 14
2020 Q2 858K $3.36M +$2.66M $3.92 13
2020 Q1 167K $520K +$44.6K $3.10 10
2019 Q4 163K $530K +$104K $3.26 10
2019 Q3 131K $484K +$46.1K $3.68 9
2019 Q2 118K $474K -$162K $4.02 8
2019 Q1 158K $47K +$47K $0.30 1